RECURRENT CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH RETINITIS PIGMENTOSA TREATED WITH CARBONIC ANHYDRASE INHIBITORS.
OBJECTIVE
To describe a rare case of recurring central serous chorioretinopathy associated with retinitis pigmentosa successfully treated with oral acetazolamide.


METHODS
A 17-year-old male with retinitis pigmentosa who developed four separate episodes of central serous chorioretinopathy over a 12-month period.


RESULTS
After the patient's fourth recurrence, he was treated with daily oral acetazolamide, which resulted in resolution of submacular fluid. He has had no subsequent recurrences while being maintained on alternating and then biweekly doses of oral acetazolamide.


CONCLUSIONS
Recurrent central serous chorioretinopathy associated with retinitis pigmentosa is a rare occurrence. The presented case demonstrates that oral acetazolamide successfully treated and may have delayed recurrent episodes of central serous chorioretinopathy in the patient with retinitis pigmentosa.
*St. John's Episcopal Hospital, Far Rockaway, New York; †Hofstra North Shore-LIJ School of Medicine, Hempstead, New York; and ‡New York Eye and Ear Infirmary of Mount Sinai, New York, New York.
Matthew
M
Pomykala
Phillip
P
Rubin
Jeffrey S
JS
Rubin
D000086:Acetazolamide / Q000627:therapeutic use*; D000284:Administration, Oral; D000293:Adolescent; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D056833:Central Serous Chorioretinopathy / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D012174:Retinitis Pigmentosa / Q000150:complications*; D016896:Treatment Outcome
D002257:Carbonic Anhydrase Inhibitors; D000086:Acetazolamide